Robert Meguid
Concepts (405)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 63 | 2025 | 2797 | 11.210 |
Why?
| | Esophagectomy | 18 | 2024 | 137 | 6.440 |
Why?
| | Surgical Procedures, Operative | 14 | 2025 | 270 | 6.180 |
Why?
| | Esophageal Neoplasms | 21 | 2025 | 333 | 6.130 |
Why?
| | Pneumonectomy | 12 | 2025 | 158 | 5.060 |
Why?
| | Surgeons | 11 | 2026 | 335 | 4.070 |
Why?
| | Thoracic Surgery | 9 | 2026 | 141 | 3.710 |
Why?
| | Quality Improvement | 24 | 2025 | 1244 | 3.100 |
Why?
| | Thoracic Surgical Procedures | 7 | 2025 | 92 | 2.960 |
Why?
| | Risk Assessment | 28 | 2025 | 3490 | 2.870 |
Why?
| | Robotic Surgical Procedures | 8 | 2025 | 149 | 2.600 |
Why?
| | Lung Neoplasms | 14 | 2025 | 2560 | 2.470 |
Why?
| | Length of Stay | 13 | 2025 | 1254 | 2.420 |
Why?
| | Retrospective Studies | 66 | 2025 | 16273 | 2.380 |
Why?
| | Inpatients | 5 | 2023 | 507 | 2.340 |
Why?
| | Preoperative Care | 7 | 2024 | 371 | 2.250 |
Why?
| | Databases, Factual | 22 | 2025 | 1444 | 2.160 |
Why?
| | Surgical Wound Infection | 7 | 2025 | 319 | 2.120 |
Why?
| | Laparoscopy | 6 | 2024 | 463 | 2.120 |
Why?
| | Ischemic Preconditioning | 4 | 2024 | 50 | 2.030 |
Why?
| | Time-to-Treatment | 5 | 2025 | 217 | 1.990 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 8 | 2025 | 1123 | 1.880 |
Why?
| | Urinary Tract Infections | 4 | 2022 | 194 | 1.810 |
Why?
| | Risk Factors | 34 | 2025 | 10438 | 1.720 |
Why?
| | Hypothermia | 2 | 2025 | 45 | 1.710 |
Why?
| | Electronic Health Records | 7 | 2023 | 1122 | 1.710 |
Why?
| | Aged | 52 | 2025 | 24574 | 1.690 |
Why?
| | Anastomosis, Surgical | 4 | 2024 | 159 | 1.690 |
Why?
| | Middle Aged | 61 | 2026 | 34434 | 1.600 |
Why?
| | Patient Readmission | 8 | 2025 | 706 | 1.580 |
Why?
| | Specialties, Surgical | 3 | 2023 | 80 | 1.570 |
Why?
| | Humans | 135 | 2026 | 141187 | 1.540 |
Why?
| | Minimally Invasive Surgical Procedures | 6 | 2024 | 179 | 1.380 |
Why?
| | United States | 39 | 2026 | 15220 | 1.330 |
Why?
| | Hospital Mortality | 11 | 2022 | 924 | 1.330 |
Why?
| | Hospitals | 8 | 2025 | 696 | 1.310 |
Why?
| | Cardiac Surgical Procedures | 3 | 2025 | 585 | 1.270 |
Why?
| | Emergency Treatment | 2 | 2021 | 125 | 1.230 |
Why?
| | Sepsis | 4 | 2023 | 616 | 1.220 |
Why?
| | Male | 70 | 2025 | 69783 | 1.180 |
Why?
| | Informed Consent | 2 | 2020 | 189 | 1.150 |
Why?
| | Female | 69 | 2026 | 75515 | 1.140 |
Why?
| | Models, Statistical | 4 | 2020 | 671 | 1.080 |
Why?
| | Adenocarcinoma | 5 | 2024 | 892 | 1.070 |
Why?
| | Esophageal Stenosis | 2 | 2024 | 55 | 1.020 |
Why?
| | Intensive Care Units | 2 | 2022 | 868 | 0.980 |
Why?
| | Guideline Adherence | 4 | 2024 | 565 | 0.930 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2023 | 74 | 0.930 |
Why?
| | Patient Discharge | 3 | 2020 | 932 | 0.890 |
Why?
| | Adult | 42 | 2026 | 39177 | 0.880 |
Why?
| | Travel | 1 | 2025 | 136 | 0.850 |
Why?
| | Shock, Septic | 2 | 2023 | 210 | 0.830 |
Why?
| | Lung Transplantation | 7 | 2023 | 322 | 0.820 |
Why?
| | Treatment Outcome | 21 | 2025 | 11120 | 0.810 |
Why?
| | Metastasectomy | 1 | 2023 | 20 | 0.800 |
Why?
| | Hernia, Hiatal | 1 | 2023 | 40 | 0.800 |
Why?
| | Perioperative Care | 1 | 2025 | 227 | 0.780 |
Why?
| | Evidence-Based Practice | 2 | 2024 | 236 | 0.760 |
Why?
| | Logistic Models | 9 | 2023 | 2086 | 0.760 |
Why?
| | Seasons | 1 | 2025 | 546 | 0.740 |
Why?
| | General Surgery | 4 | 2021 | 199 | 0.720 |
Why?
| | Neoplasm Staging | 8 | 2025 | 1398 | 0.700 |
Why?
| | Critical Pathways | 1 | 2022 | 106 | 0.700 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 277 | 0.680 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 23 | 0.660 |
Why?
| | Patient Admission | 1 | 2022 | 203 | 0.660 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 45 | 0.650 |
Why?
| | Rectal Prolapse | 1 | 2020 | 24 | 0.630 |
Why?
| | Physicians, Women | 3 | 2026 | 87 | 0.620 |
Why?
| | Patient Satisfaction | 2 | 2022 | 695 | 0.610 |
Why?
| | Thoracotomy | 1 | 2019 | 80 | 0.610 |
Why?
| | Cohort Studies | 11 | 2023 | 5799 | 0.600 |
Why?
| | Anastomotic Leak | 4 | 2024 | 43 | 0.590 |
Why?
| | Prognosis | 9 | 2025 | 4073 | 0.590 |
Why?
| | Aftercare | 1 | 2020 | 218 | 0.580 |
Why?
| | Thoracoscopy | 2 | 2020 | 58 | 0.570 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 337 | 0.570 |
Why?
| | Outpatients | 1 | 2022 | 420 | 0.570 |
Why?
| | Hospitals, Teaching | 2 | 2009 | 115 | 0.560 |
Why?
| | Patient Transfer | 2 | 2019 | 181 | 0.550 |
Why?
| | Time Factors | 10 | 2025 | 6956 | 0.530 |
Why?
| | Survival Rate | 11 | 2025 | 1970 | 0.520 |
Why?
| | Neoadjuvant Therapy | 4 | 2024 | 419 | 0.520 |
Why?
| | Morbidity | 4 | 2023 | 322 | 0.510 |
Why?
| | Stomach | 4 | 2024 | 110 | 0.510 |
Why?
| | Preoperative Period | 4 | 2021 | 142 | 0.510 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 882 | 0.490 |
Why?
| | Tissue and Organ Procurement | 4 | 2023 | 316 | 0.470 |
Why?
| | Postoperative Care | 2 | 2016 | 279 | 0.450 |
Why?
| | Data Collection | 1 | 2017 | 661 | 0.440 |
Why?
| | Trachea | 1 | 2016 | 255 | 0.440 |
Why?
| | Aged, 80 and over | 10 | 2025 | 7856 | 0.420 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 286 | 0.410 |
Why?
| | Constriction, Pathologic | 2 | 2024 | 238 | 0.400 |
Why?
| | Clinical Protocols | 2 | 2024 | 273 | 0.380 |
Why?
| | Quality of Life | 2 | 2024 | 2999 | 0.380 |
Why?
| | Emergencies | 2 | 2025 | 179 | 0.360 |
Why?
| | Machine Learning | 4 | 2023 | 553 | 0.360 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2011 | 162 | 0.360 |
Why?
| | Societies, Medical | 3 | 2024 | 855 | 0.340 |
Why?
| | Prospective Studies | 6 | 2024 | 7739 | 0.330 |
Why?
| | Conversion to Open Surgery | 2 | 2020 | 17 | 0.330 |
Why?
| | Veterans | 1 | 2022 | 1514 | 0.330 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 433 | 0.320 |
Why?
| | Thoracic Neoplasms | 2 | 2020 | 39 | 0.320 |
Why?
| | Pregnancy Complications | 1 | 2015 | 587 | 0.310 |
Why?
| | Pandemics | 5 | 2025 | 1653 | 0.310 |
Why?
| | Aneurysm, Ruptured | 1 | 2009 | 35 | 0.300 |
Why?
| | Propensity Score | 3 | 2019 | 328 | 0.300 |
Why?
| | Pain, Postoperative | 2 | 2023 | 309 | 0.300 |
Why?
| | Quality Assurance, Health Care | 3 | 2021 | 331 | 0.290 |
Why?
| | Incidence | 3 | 2025 | 2794 | 0.280 |
Why?
| | Triage | 2 | 2020 | 246 | 0.270 |
Why?
| | Disease-Free Survival | 3 | 2023 | 715 | 0.270 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 67 | 0.270 |
Why?
| | Reoperation | 2 | 2023 | 588 | 0.260 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 80 | 0.260 |
Why?
| | Follow-Up Studies | 6 | 2025 | 5200 | 0.260 |
Why?
| | Pancreaticoduodenectomy | 1 | 2008 | 129 | 0.260 |
Why?
| | Chylothorax | 2 | 2017 | 20 | 0.250 |
Why?
| | Diaphragm | 2 | 2023 | 45 | 0.250 |
Why?
| | Coronary Artery Bypass | 2 | 2025 | 243 | 0.250 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3348 | 0.250 |
Why?
| | Career Choice | 2 | 2026 | 232 | 0.240 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 246 | 0.240 |
Why?
| | Pneumonia | 2 | 2023 | 656 | 0.240 |
Why?
| | Age Factors | 2 | 2025 | 3292 | 0.240 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 308 | 0.240 |
Why?
| | Chemoradiotherapy | 2 | 2024 | 232 | 0.240 |
Why?
| | Pancreatectomy | 1 | 2008 | 262 | 0.230 |
Why?
| | Postoperative Hemorrhage | 2 | 2023 | 89 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 374 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 371 | 0.220 |
Why?
| | Case-Control Studies | 5 | 2024 | 3588 | 0.220 |
Why?
| | Organizational Culture | 1 | 2026 | 162 | 0.220 |
Why?
| | Vulnerable Populations | 1 | 2025 | 169 | 0.210 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1597 | 0.210 |
Why?
| | Geriatric Assessment | 1 | 2025 | 221 | 0.210 |
Why?
| | Spouses | 1 | 2025 | 108 | 0.210 |
Why?
| | Workplace | 1 | 2026 | 269 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2019 | 1018 | 0.200 |
Why?
| | Smoking | 2 | 2012 | 1601 | 0.200 |
Why?
| | Respiratory Paralysis | 1 | 2023 | 4 | 0.200 |
Why?
| | Comorbidity | 3 | 2022 | 1662 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3709 | 0.200 |
Why?
| | Mentors | 1 | 2025 | 210 | 0.200 |
Why?
| | Herniorrhaphy | 1 | 2023 | 76 | 0.190 |
Why?
| | Risk Adjustment | 1 | 2023 | 81 | 0.190 |
Why?
| | Fluorouracil | 1 | 2023 | 206 | 0.190 |
Why?
| | Algorithms | 3 | 2019 | 1763 | 0.190 |
Why?
| | Colorectal Surgery | 1 | 2022 | 30 | 0.180 |
Why?
| | Advisory Committees | 1 | 2023 | 220 | 0.180 |
Why?
| | Qualitative Research | 3 | 2026 | 1516 | 0.180 |
Why?
| | Social Determinants of Health | 1 | 2025 | 269 | 0.180 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 1073 | 0.180 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1306 | 0.180 |
Why?
| | Periodicals as Topic | 1 | 2024 | 217 | 0.180 |
Why?
| | Databases as Topic | 1 | 2021 | 69 | 0.170 |
Why?
| | Heart Transplantation | 2 | 2023 | 714 | 0.170 |
Why?
| | Tissue Donors | 2 | 2023 | 405 | 0.170 |
Why?
| | Leadership | 1 | 2025 | 396 | 0.170 |
Why?
| | Family | 1 | 2025 | 680 | 0.160 |
Why?
| | Focus Groups | 1 | 2023 | 565 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 276 | 0.160 |
Why?
| | Lung | 2 | 2024 | 4134 | 0.160 |
Why?
| | Arthroplasty | 1 | 2020 | 53 | 0.160 |
Why?
| | Fear | 1 | 2023 | 346 | 0.160 |
Why?
| | Robotics | 1 | 2021 | 88 | 0.160 |
Why?
| | Intermediate Care Facilities | 1 | 2019 | 4 | 0.160 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 37 | 0.160 |
Why?
| | Benchmarking | 1 | 2021 | 188 | 0.160 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 194 | 0.150 |
Why?
| | Physical Fitness | 1 | 2020 | 206 | 0.150 |
Why?
| | Glutamine | 1 | 1999 | 107 | 0.150 |
Why?
| | Burnout, Professional | 1 | 2026 | 455 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 522 | 0.150 |
Why?
| | Geography | 1 | 2019 | 201 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2019 | 125 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 109 | 0.150 |
Why?
| | Heat-Shock Proteins | 1 | 1999 | 142 | 0.150 |
Why?
| | Hospitals, University | 1 | 2018 | 175 | 0.140 |
Why?
| | Overweight | 1 | 2023 | 587 | 0.140 |
Why?
| | Skilled Nursing Facilities | 1 | 2019 | 140 | 0.140 |
Why?
| | Forecasting | 1 | 2019 | 384 | 0.140 |
Why?
| | United States Department of Veterans Affairs | 1 | 2022 | 707 | 0.140 |
Why?
| | Altruism | 1 | 2017 | 28 | 0.130 |
Why?
| | Internship and Residency | 3 | 2021 | 1235 | 0.130 |
Why?
| | Eating | 3 | 1995 | 392 | 0.130 |
Why?
| | Medical Oncology | 1 | 2020 | 316 | 0.130 |
Why?
| | Thoracic Wall | 1 | 2017 | 19 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 585 | 0.130 |
Why?
| | Pylorus | 1 | 2017 | 18 | 0.130 |
Why?
| | Gastric Outlet Obstruction | 1 | 2017 | 12 | 0.130 |
Why?
| | Self Efficacy | 1 | 2020 | 405 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 287 | 0.130 |
Why?
| | Parenteral Nutrition | 2 | 1995 | 105 | 0.130 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 40 | 0.130 |
Why?
| | Medically Underserved Area | 1 | 2017 | 96 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 289 | 0.130 |
Why?
| | Pleural Effusion | 1 | 2017 | 60 | 0.130 |
Why?
| | Abscess | 1 | 2017 | 77 | 0.130 |
Why?
| | Frailty | 1 | 2019 | 173 | 0.120 |
Why?
| | Pain Management | 1 | 2020 | 396 | 0.120 |
Why?
| | Neuromuscular Agents | 1 | 2017 | 41 | 0.120 |
Why?
| | Home Care Services | 1 | 2019 | 259 | 0.120 |
Why?
| | Clinical Competence | 3 | 2021 | 1202 | 0.120 |
Why?
| | Postoperative Period | 4 | 2021 | 355 | 0.120 |
Why?
| | Botulinum Toxins, Type A | 1 | 2017 | 52 | 0.120 |
Why?
| | Chyle | 1 | 2015 | 4 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1490 | 0.120 |
Why?
| | Prevalence | 1 | 2022 | 2772 | 0.120 |
Why?
| | Nutritional Support | 1 | 2015 | 40 | 0.120 |
Why?
| | Health Status | 1 | 2021 | 823 | 0.120 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 296 | 0.120 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 65 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1787 | 0.110 |
Why?
| | Altitude | 1 | 2019 | 475 | 0.110 |
Why?
| | Osteomyelitis | 1 | 2017 | 139 | 0.110 |
Why?
| | Orthopedics | 1 | 2017 | 154 | 0.110 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2019 | 344 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2020 | 550 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2019 | 582 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 703 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 122 | 0.110 |
Why?
| | Body Mass Index | 1 | 2023 | 2382 | 0.110 |
Why?
| | Hospitals, Veterans | 1 | 2015 | 255 | 0.110 |
Why?
| | Proportional Hazards Models | 3 | 2018 | 1261 | 0.110 |
Why?
| | Radiosurgery | 1 | 2018 | 392 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1973 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2020 | 666 | 0.100 |
Why?
| | Colorado | 3 | 2018 | 4610 | 0.100 |
Why?
| | Health Services Research | 1 | 2016 | 406 | 0.100 |
Why?
| | Proteins | 1 | 1999 | 1010 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1143 | 0.100 |
Why?
| | Hospitalization | 2 | 2021 | 2255 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2024 | 52 | 0.100 |
Why?
| | Leiomyosarcoma | 1 | 2012 | 29 | 0.100 |
Why?
| | Decision Making | 1 | 2020 | 961 | 0.090 |
Why?
| | RNA, Messenger | 2 | 1999 | 2828 | 0.090 |
Why?
| | Heart Neoplasms | 1 | 2012 | 56 | 0.090 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 84 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2015 | 312 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1478 | 0.090 |
Why?
| | Energy Intake | 1 | 1995 | 513 | 0.090 |
Why?
| | Endoleak | 1 | 2011 | 17 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 2011 | 8 | 0.090 |
Why?
| | Intestinal Fistula | 1 | 2011 | 17 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2025 | 5929 | 0.090 |
Why?
| | Transcription Factors | 1 | 1999 | 1703 | 0.090 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 153 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1336 | 0.090 |
Why?
| | Pulmonary Valve | 1 | 2012 | 93 | 0.090 |
Why?
| | Body Composition | 1 | 1995 | 701 | 0.080 |
Why?
| | Transplant Recipients | 2 | 2023 | 178 | 0.080 |
Why?
| | Adipose Tissue | 1 | 1995 | 647 | 0.080 |
Why?
| | Aortic Diseases | 1 | 2011 | 119 | 0.080 |
Why?
| | Hospitals, District | 1 | 2009 | 6 | 0.080 |
Why?
| | Obesity | 1 | 2023 | 3004 | 0.080 |
Why?
| | Pancreas, Exocrine | 1 | 2008 | 6 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2902 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 521 | 0.070 |
Why?
| | Patient Selection | 3 | 2020 | 688 | 0.070 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 263 | 0.070 |
Why?
| | SEER Program | 1 | 2008 | 220 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1049 | 0.070 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 326 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2008 | 166 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 674 | 0.060 |
Why?
| | Consensus | 2 | 2020 | 704 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1114 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 509 | 0.060 |
Why?
| | Hypertension | 1 | 2015 | 1252 | 0.060 |
Why?
| | Cause of Death | 1 | 2008 | 440 | 0.060 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 330 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 750 | 0.060 |
Why?
| | Graft Survival | 2 | 2023 | 499 | 0.060 |
Why?
| | Sexism | 1 | 2026 | 68 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Job Satisfaction | 1 | 2026 | 221 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 908 | 0.050 |
Why?
| | Diagnostic Tests, Routine | 1 | 2024 | 110 | 0.050 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2025 | 141 | 0.050 |
Why?
| | Triglycerides | 2 | 2015 | 514 | 0.050 |
Why?
| | Odds Ratio | 2 | 2019 | 1052 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 7070 | 0.050 |
Why?
| | Interpersonal Relations | 1 | 2025 | 411 | 0.040 |
Why?
| | Colectomy | 1 | 2022 | 107 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 257 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 208 | 0.040 |
Why?
| | Fatigue | 1 | 2023 | 338 | 0.040 |
Why?
| | Registries | 2 | 2025 | 2135 | 0.040 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 959 | 0.040 |
Why?
| | Learning Curve | 1 | 2021 | 70 | 0.040 |
Why?
| | Professional Practice Gaps | 1 | 2020 | 14 | 0.040 |
Why?
| | Adolescent | 3 | 2023 | 22007 | 0.040 |
Why?
| | Child | 1 | 2020 | 22308 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 164 | 0.040 |
Why?
| | Glutaminase | 1 | 1999 | 11 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 1999 | 33 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2070 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 48 | 0.040 |
Why?
| | Hydrolysis | 1 | 1999 | 196 | 0.040 |
Why?
| | Walk Test | 1 | 2019 | 80 | 0.040 |
Why?
| | Serum Albumin | 1 | 2019 | 153 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2009 | 329 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 82 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 830 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 286 | 0.030 |
Why?
| | Cell Division | 1 | 1999 | 798 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1999 | 198 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 586 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 382 | 0.030 |
Why?
| | Alternative Splicing | 1 | 1999 | 232 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 208 | 0.030 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2017 | 29 | 0.030 |
Why?
| | Clinical Audit | 1 | 2016 | 13 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 424 | 0.030 |
Why?
| | Regression Analysis | 1 | 2019 | 1020 | 0.030 |
Why?
| | Cell Line | 2 | 1999 | 2885 | 0.030 |
Why?
| | Education | 1 | 2017 | 109 | 0.030 |
Why?
| | Gastric Emptying | 1 | 2017 | 36 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 339 | 0.030 |
Why?
| | Competency-Based Education | 1 | 2017 | 75 | 0.030 |
Why?
| | HIV Infections | 1 | 2012 | 3017 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 502 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 464 | 0.030 |
Why?
| | Cadaver | 1 | 2017 | 298 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 335 | 0.030 |
Why?
| | Operative Time | 1 | 2016 | 154 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2504 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 3469 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 56 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 740 | 0.030 |
Why?
| | Dietary Fiber | 1 | 2015 | 57 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 167 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1820 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 92 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 145 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2015 | 136 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2574 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1995 | 158 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1243 | 0.030 |
Why?
| | Glycogen | 1 | 1993 | 54 | 0.030 |
Why?
| | Dietary Fats | 1 | 2015 | 300 | 0.030 |
Why?
| | Poverty | 1 | 2017 | 530 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5636 | 0.030 |
Why?
| | Rats | 4 | 1995 | 5629 | 0.030 |
Why?
| | Mortality | 1 | 2015 | 358 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1487 | 0.020 |
Why?
| | Staphylococcus epidermidis | 1 | 1993 | 77 | 0.020 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2012 | 145 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 62 | 0.020 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2012 | 78 | 0.020 |
Why?
| | Echocardiography, Transesophageal | 1 | 2012 | 128 | 0.020 |
Why?
| | Carbon Monoxide | 1 | 2012 | 83 | 0.020 |
Why?
| | Catheterization, Central Venous | 1 | 1993 | 116 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1116 | 0.020 |
Why?
| | Anesthesia, General | 1 | 1992 | 117 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 633 | 0.020 |
Why?
| | Peritonitis | 1 | 2011 | 87 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1816 | 0.020 |
Why?
| | Body Weight | 1 | 1995 | 996 | 0.020 |
Why?
| | Endoscopy, Digestive System | 1 | 2011 | 135 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2520 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 222 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 1993 | 392 | 0.020 |
Why?
| | Rats, Inbred F344 | 3 | 1993 | 269 | 0.020 |
Why?
| | California | 1 | 2009 | 462 | 0.020 |
Why?
| | Receptors, Notch | 1 | 2008 | 87 | 0.020 |
Why?
| | Safety | 1 | 2009 | 356 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 891 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 413 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2250 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2011 | 355 | 0.020 |
Why?
| | Liver | 1 | 1995 | 1819 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2008 | 618 | 0.010 |
Why?
| | Academic Medical Centers | 1 | 2008 | 528 | 0.010 |
Why?
| | Graft Rejection | 1 | 2008 | 544 | 0.010 |
Why?
| | Animals | 5 | 2008 | 37657 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1242 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13673 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2180 | 0.010 |
Why?
| | Brain | 1 | 1993 | 2858 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1999 | 198 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 274 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 330 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 363 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 391 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 302 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 533 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 274 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 824 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2180 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2158 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 5144 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2929 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 167 | 0.010 |
Why?
| | Chloral Hydrate | 1 | 1992 | 3 | 0.010 |
Why?
| | Periodicity | 1 | 1992 | 57 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 328 | 0.010 |
Why?
| | Organ Specificity | 1 | 1993 | 312 | 0.010 |
Why?
| | Mice | 1 | 2008 | 18048 | 0.010 |
Why?
| | Food Preferences | 1 | 1992 | 124 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1992 | 508 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1993 | 4404 | 0.000 |
Why?
|
|
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|